Customized Titanium Membrane for Growing Jaw Bone Horizontally

The Use of Customized Titanium Membrane for Horizontal Ridge Augmentation With Simultaneous Implant Placement

Status

Withdrawn

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02227719

Enrollment

Registered

2014-08-28

Start date

2015-09-30

Completion date

2016-06-30

Last updated

2023-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Gain

Keywords

after augmentation, procedure

Brief summary

A single center, randomized, controlled, parallel-arm study is planned to investigate clinical outcomes of horizontal ridge augmentation with simultaneous single implant placement, using the newly designed Ti-membrane. Twenty-four adult subjects who fulfill the inclusion criteria will be enrolled. They will be randomly placed into one of two treatment groups: the customized titanium membrane (Cti-mem) or the collagen membrane (CM) group as a control. The decision of which material to use will be made after an implant is placed. Primary closure of the surgical site will be attempted for 4 months (+/- 1 month), after which the implants will be surgically uncovered and restored. Outcome analyses will be performed until 1-year after the crown will be placed, or 18 months (- 1 or +4 months) from the implant surgery. Clinical and radiographic parameters will be compared between the two experimental groups. The primary outcome is linear increase of horizontal ridge width from direct measurements.

Interventions

DEVICECTI

CTI is the titanium mesh

DEVICECollagen membrane

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Male or female, age \>18 * Overall good, stable health * A single missing mandibular 1st molar for at least 3 months

Exclusion criteria

* Any medical conditions that may contradict implant and bone surgery or influence the outcome (detailed criteria in case report form) * Pregnancy or lactating mothers * Current heavy smokers (\>10 cigarettes/day) or previous heavy smokers who have quit less than one year * Unstable or unsuitable oral conditions for implant and bone surgery (detailed criteria in case report form)

Design outcomes

Primary

Measure	Time frame
linear bone gain	4 months after surgery

Secondary

Measure	Time frame
implant marginal bone level	18 months after baseline surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026